Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026)
Adaptin Bio (APTN) reported Other Non-Current Liabilities of $551269.0 for Q1 2026, little changed year-over-year from $551269.0 in Q1 2025, and little changed sequentially from $551269.0 in Q4 2025.
Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends
Adaptin Bio has disclosed Other Non-Current Liabilities across 2 years of filings, most recently posting $551269.0 for Q1 2026.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $551269.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $551269.0 (changed 0.0% YoY) and the FY2025 annual result came in at $551269.0, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $551269.0 in Q1 2026, from $551269.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $551269.0 in Q1 2025 and bottomed at $551269.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551,269.00 |
| Dec 31, 2025 | 551,269.00 |
| Sep 30, 2025 | 551,269.00 |
| Jun 30, 2025 | 551,269.00 |
| Mar 31, 2025 | 551,269.00 |